ArticleIranian journal of child neurology2022
Efficacy of Addition of Atomoxetine to Speech Therapy in Stuttering Severity of Children Aged 4-12 Years: A Double-Blind Randomized Controlled Trial.
Farzad Ahmadabadi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.